CVJ Stock Overview
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, supplying, and selling medicinal cannabis.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Cann Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.029 |
| 52 Week High | AU$0.11 |
| 52 Week Low | AU$0.029 |
| Beta | 0.92 |
| 1 Month Change | 0% |
| 3 Month Change | -28.36% |
| 1 Year Change | -67.27% |
| 3 Year Change | -90.46% |
| 5 Year Change | -98.03% |
| Change since IPO | -92.42% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVJ | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.3% | 0.5% |
| 1Y | -67.3% | -28.6% | 1.3% |
Return vs Industry: CVJ underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: CVJ underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| CVJ volatility | |
|---|---|
| CVJ Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CVJ's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CVJ's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Peter Koetsier | www.canngrouplimited.com |
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, supplying, and selling medicinal cannabis. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
Cann Group Limited Fundamentals Summary
| CVJ fundamental statistics | |
|---|---|
| Market cap | €16.47m |
| Earnings (TTM) | -€17.77m |
| Revenue (TTM) | €12.95m |
1.3x
P/S Ratio-0.9x
P/E RatioIs CVJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVJ income statement (TTM) | |
|---|---|
| Revenue | AU$21.34m |
| Cost of Revenue | -AU$955.00k |
| Gross Profit | AU$22.29m |
| Other Expenses | AU$51.58m |
| Earnings | -AU$29.28m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.067 |
| Gross Margin | 104.48% |
| Net Profit Margin | -137.24% |
| Debt/Equity Ratio | 129.2% |
How did CVJ perform over the long term?
See historical performance and comparison